المصدر: A Phase 1, Open-Label Study in Hemodialysis and Non-Hemodialysis Patients With Severe Chronic Kidney Disease to Evaluate the Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02837237Test

المصدر: An Open-Label, Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects With a Separate Panel in Subjects With Mild to Moderate Renal Impairment

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02653014Test